Skip to Main Content

Paper Details

Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodies.
Brain Behav
8
2022
Author NameAffiliation
Martin GlasDivision of Clinical Neurooncology, University Hospital Essen, University Duisburg-Essen
  • 1 - 1

Datasets

Release 1.2